These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A shadow of Epstein-Barr virus in the pathogenesis of atopic diseases. Okudaira H; Shuto H; Shuto C; Chiba T; Akiyama H; Ohta I; Matsuzaki G Clin Exp Allergy; 2001 Jan; 31(1):18-24. PubMed ID: 11167946 [No Abstract] [Full Text] [Related]
24. [Clinical aspects and diagnosis of Epstein-Barr virus infections]. Witkowska-Vogtt E Przegl Epidemiol; 2002; 56 Suppl 4():25-33. PubMed ID: 14750257 [No Abstract] [Full Text] [Related]
25. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection. Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268 [TBL] [Abstract][Full Text] [Related]
32. Lack of Epstein-Barr virus infection of synovial membranes in patients with rheumatoid arthritis: comment on the article by Niedobitek et al. Brousset P Arthritis Rheum; 2000 Nov; 43(11):2614. PubMed ID: 11083292 [No Abstract] [Full Text] [Related]
33. [Purification and application of viral capsid antigen of Epstein-Barr virus]. Zhou W; Gu S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):252-5. PubMed ID: 15617341 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology. Radtke M; Gärtner B; Franke D Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650 [No Abstract] [Full Text] [Related]
35. Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma. Gasser O; Wolbers M; Steffen I; Hirsch HH; Battegay M; Hess C AIDS; 2007 Jul; 21(12):1664-6. PubMed ID: 17630573 [No Abstract] [Full Text] [Related]
36. [Infection by Epstein-Barr virus and multiple sclerosis]. Alonso A; Egüés Olazábal N; Ayo Martín O Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867 [TBL] [Abstract][Full Text] [Related]
37. [The relationship between Epstein-Barr virus and rheumatoid arthritis]. Xu WD; Shi GY; Cai XH Zhonghua Nei Ke Za Zhi; 1985 Aug; 24(8):457-9, 509. PubMed ID: 2996850 [No Abstract] [Full Text] [Related]
38. Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model. Fadlallah S; Hussein H; Jallad MA; Shehab M; Jurjus AR; Matar GM; Rahal EA Front Immunol; 2021; 12():672752. PubMed ID: 34040613 [TBL] [Abstract][Full Text] [Related]
39. EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease. Miceli-Richard C; Mariette X Joint Bone Spine; 2007 Dec; 74(6):560-2. PubMed ID: 17988922 [No Abstract] [Full Text] [Related]
40. Microchimerism detection by human leucocyte antigen-specific quantitative-polymerase chain reaction analysis in recipients of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes. Lucas KG; Nelson JL; Erickson TD; Sun Q Br J Haematol; 2005 May; 129(3):443-4. PubMed ID: 15842671 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]